Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 141

1.

Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients.

Giovannoni G, Cohen JA, Coles AJ, Hartung HP, Havrdova E, Selmaj KW, Margolin DH, Lake SL, Kaup SM, Panzara MA, Compston DA; CARE-MS II Investigators.

Neurology. 2016 Nov 8;87(19):1985-1992. Epub 2016 Oct 12.

2.

Ex vivo expanded regulatory T cells CD4+CD25+FoxP3+CD127Low develop strong immunosuppressive activity in patients with remitting-relapsing multiple sclerosis.

Lifshitz GV, Zhdanov DD, Lokhonina AV, Eliseeva DD, Lyssuck EY, Zavalishin IA, Bykovskaia SN.

Autoimmunity. 2016 Sep;49(6):388-396. Epub 2016 Jul 16.

PMID:
27424664
3.

[The treatment by expanded ex vivo autologous regulatory T-cells CD4+CD25+FoxP3+CD127low restores the balance of immune system in patients with remitting-relapsing multiple sclerosis].

Eliseeva DD, Lifshitz GV, Lokhonina AV, Zhdanov DD, Zavalishin IA, Bykovskaia SN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(2 Pt 2):54-62. doi: 10.17116/jnevro20161162254-62. Russian.

PMID:
27070362
4.

[Criteria of withdrawal of first-line DMT and substitution for second-line drugs (treatment escalation) basing on MRI results].

Krotenkova MV, Morozova SN, Briukhov VV, Zavalishin IA, Peresedova AV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(2 Pt 2):79-80. doi: 10.17116/jnevro20151152279-80. Russian. No abstract available.

PMID:
26081343
5.

[No support for the hypothesis of chronic cerebrospinal venous insufficiency in multiple sclerosis].

Peresedova AV, Chechetkin AO, Lebedeva MA, Askarova LSh, Zavalishin IA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(10 Pt 2):37-42. Russian.

PMID:
25591533
6.

[MRI-diagnosis of progressive multifocal leukoencephalopathy].

Kulikova SN, Briukhov VV, Peresedova AV, Krotenkova MV, Zavalishin IA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(10):95-101. Review. Russian. No abstract available.

PMID:
24404655
7.

[Compensatory mechanisms in multiple sclerosis(review)].

Peresedova AV, Zavalishin IA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(2 Pt 2):17-22. Review. Russian.

PMID:
23675603
8.

[Physical rehabilitation in multiple sclerosis: general principles and high-tech approaches].

Peresedova AV, Chernikova LA, Zavalishin IA.

Vestn Ross Akad Med Nauk. 2013;(10):14-21. Review. Russian.

PMID:
24640715
9.

[Prion diseases].

Stoĭda NI, Zavalishin IA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(9 Pt 2):59-63. Review. Russian.

PMID:
23235426
10.

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.

Coles AJ, Twyman CL, Arnold DL, Cohen JA, Confavreux C, Fox EJ, Hartung HP, Havrdova E, Selmaj KW, Weiner HL, Miller T, Fisher E, Sandbrink R, Lake SL, Margolin DH, Oyuela P, Panzara MA, Compston DA; CARE-MS II investigators.

Lancet. 2012 Nov 24;380(9856):1829-39. doi: 10.1016/S0140-6736(12)61768-1. Epub 2012 Nov 1.

PMID:
23122650
11.

[Results of a comparative clinical trial of the Russian Β - interferon-1b bioanalogue (infibeta)].

Popova EV, Boĭko AN, Vasil'ev AV, Davydovskaia MV, Zavalishin IA, Kotov SV, Krotenkova MV, Khachanova NV, Sharanova SN, Shchur SG, Iakushina TI.

Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(5):56-61. Russian.

PMID:
22951783
12.

[Diffusion-tensor magnetic resonance tomography and tractography in multiple sclerosis: a review].

Kulikova SN, Briukhov VV, Peresedova AV, Krotenkova MV, Zavalishin IA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(2 Pt 2):52-9. Review. Russian.

PMID:
22737764
13.

[The role of regulatory T cells in the development of autoimmune process in multiple sclerosis].

Eliseeva DD, Zavalishin IA, Karaulov AV, Bykovskaia SN.

Vestn Ross Akad Med Nauk. 2012;(3):68-74. Review. Russian.

PMID:
22712278
14.

[Clinical significance of T-regulatory cells in multiple sclerosis].

Eliseeva DD, Zavalishin IA, Bykovskaia SN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(2 Pt 2):29-33. Russian.

PMID:
22677676
15.

[Diagnosis and treatment of multiple sclerosis].

Zavalishin IA, Peresedova AV, Stoĭda NI, Gur'ianova OE, Arzumian NSh, Alekseeva NS, Eliseeva DD, Gulevskaia TS, Briukhov VV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(6):89-96. Review. Russian. No abstract available.

PMID:
21905343
16.

[Axonopathy in the pathogenesis of multiple sclerosis, peripheral diffuse and local motor neuropathies and motor neuron disease].

Merkulov IuA, Merkulova DM, Iosifova OA, Zavalishin IA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(8):4-7. Russian.

PMID:
20823822
17.

[Cortical reorganization in multiple sclerosis with movement disorders detected by functional MRI (own observations and literature data)].

Peresedova AV, Konovalov RN, Krotenkova MV, Zavalishin IA, Trifonova OV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2009;109(7 Suppl 2):38-43. Russian.

PMID:
19891347
18.

[Differential diagnosis of multifocal motor neuropathy and related diseases].

Merkulova DM, Iosifova OA, Merkulov IuA, Zavalishin IA.

Klin Med (Mosk). 2009;87(9):54-7. Russian.

PMID:
19882883
19.

[The role of apolipoprotein E in patients with amyotrophic lateral sclerosis (a clinical and genetic study)].

Kutakova EV, Zakharova MN, Illarioshkin SN, Kliushnikov SA, Zavalishin IA, Ivanova-Smolenskaia IA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2009;109(2):51-4. Russian.

PMID:
19365373
20.

Gene therapy of amyotrophic lateral sclerosis.

Zavalishin IA, Bochkov NP, Suslina ZA, Zakharova MN, Tarantul VZ, Naroditskiy BS, Suponeva NA, Illarioshkin SN, Shmarov MM, Logunov DY, Tutyhina IL, Verkhovskaya LV, Sedova ES, Vasiliev AV, Brylev LV, Ginzburg AL.

Bull Exp Biol Med. 2008 Apr;145(4):483-6.

PMID:
19110600

Supplemental Content

Loading ...
Support Center